Why the study?
Whether metabolically healthy obesity is a truly benign phenomenon remains uncertain, and obesity is linked to low-grade systemic inflammation and endothelial dysfunction.
Does metabolically healthy obesity increase arterial stiffness and systemic inflammation compared to metabolically healthy normal weight?
Cross-Sectional (n=150)
Does metabolically healthy obesity increase arterial stiffness and systemic inflammation compared to metabolically healthy normal weight?
p-value: p=<.05
Metabolically healthy obesity is associated with increased arterial stiffness and systemic inflammation compared to normal-weight individuals, suggesting it is not a benign cardiovascular condition.
OBJECTIVES: Although metabolically healthy obesity (MHO) has begun to be seen as a being benign phenomenon, this conclusion is still not completely certain. Obesity is also associated with low-grade systemic inflammation and endothelial dysfunction. Thus, we aimed to assess Pulse Wave Velocity (PWV) as a marker of arterial stiffness and CV risk among individuals with MHO, metabolically unhealthy obesity (MUO), and metabolically healthy normal-weight (MHN). METHODS: 150 participants (n = 50 MHO, n = 50 MUO, n = 50 MHN) who had been admitted to our outpatient clinics were enrolled in this cross-sectional study. Demographic, anthropometric, clinical, and laboratory data, including hs-CRP and PWV, were recorded for all subjects. RESULTS: hs-CRP and PWV were higher in MUO and MHO than MHN individuals (P < .05). hs-CRP showed a strong positive correlation with PWV (r = 0.85, P < .001). After adjusting for other risk factors, multivariate linear regression analysis showed that the PWV was independently associated with BMI (β = 0.08, P = .03), WC (β = 0.04, P = .04) and hs-CRP (β = 6.08, P < .001). CONCLUSIONS: PWV, which is an important non-invasive marker of cardiovascular risk, is higher in MHO than in MHN as in MUO individuals. Moreover, PWV was positively correlated with the serum hs-CRP level as a conventional marker for systemic inflammation. Thus, MHO can be seen as a cardiometabolic risk marker.
No takes yet. Share an insight, caveat, or question.
Canpolat et al. (2021) conducted a cross-sectional in Obesity and metabolic phenotypes (n=150). Metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) vs. Metabolically healthy normal-weight (MHN) was evaluated on Pulse Wave Velocity (PWV) and hs-CRP (p=<.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: